Back
Black Diamond Therapeutics 10K Form
Sell
40
BDTX
Black Diamond Therapeutics
Last Price:
2.55
Seasonality Move:
28.2%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BDTX News And Ratings
See the #1 stock for the next 7 days that we like better than BDTX
BDTX Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-11.32M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.72 |
| Price / Book: | 1.48 |
Profitability
| EPS (TTM): | -1.33000 |
|---|---|
| Net Income (TTM): | $-73.1M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Black Diamond Therapeutics Earnings Forecast
Key Black Diamond Therapeutics Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 7 years have been positive in 2 years.
Black Diamond Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BDTX |
| CUSIP: | 09203E |
| Website: | blackdiamondtherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BDTX Technical Analysis vs Fundamental Analysis
Sell
40
Black Diamond Therapeutics (BDTX)
is a Sell
Is Black Diamond Therapeutics a Buy or a Sell?
-
Black Diamond Therapeutics stock is rated a Sell
The current Black Diamond Therapeutics [BDTX] share price is $2.54. The Score for BDTX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.